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SUMMARY
High-throughput oligonucleotide microarrays are commonly employed to investigate genetic disease,
including cancer. The algorithms employed to extract genotypes and copy number variation function
optimally for diploid genomes usually associated with inherited disease. However, cancer genomes are
aneuploid in nature leading to systematic errors when using these techniques. We introduce a prepro-
cessing transformation and hidden Markov model algorithm bespoke to cancer. This produces genotype
classiﬁcation, speciﬁcation of regions of loss of heterozygosity, and absolute allelic copy number segmen-
tation. Accurate prediction is demonstrated with a combination of independent experimental techniques.
These methods are exempliﬁed with affymetrix genome-wide SNP6.0 data from 755 cancer cell lines,
enabling inference upon a number of features of biological interest. These data and the coded algorithm
are freely available for download.
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1. INTRODUCTION
Cancer is a genetic disease arising when mutations of genes provide sufﬁcient growth advantage to in-
duce neoplastic transformation. For example, the p14arf and p16ink4a proteins coded from the CDKN2A
tumor suppressor gene locus regulate RB1 and p53, controlling cell cycle and apoptosis, respectively. Ho-
mozygous deletion of this locus removes such control, promoting cell division and providing a selective
advantage towards cancer. Tumor suppressor genes can also be inactivated by small single nucleotide mu-
tations, such as p53 and PTEN, for example. The mutation inactivates 1 allele, and hemizygous deletion
can remove the other allele to achieve functional inactivation. This results in loss of homozygosity (LOH)
across the loci. Conversely, genomic ampliﬁcation of ERBB2 contributes to uncontrolled positive growth
signaling. The copy number status of cancer genes can serve as prognostic markers in various cancer types
and, as in the case of ERBB2, can constitute an effective target for therapy. It is therefore imperative to be
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able to accurately assess cancer genomes for copy number changes and to accurately analyze this data tak-
ing into account the full information content available. Given that genotypes enable sample identiﬁcation,
microarrays offer an all encompassing solution.
These platforms perform genotyping experiments across millions of single nucleotide polymorphisms
(SNPs) simultaneously, which produce copy number information in addition to SNP genotypes. Microar-
ray technologies have a proven record for investigating genetic disease. For example, oligonucleotide
microarrays produce both genotypes applied to genome-wide association studies (WTCCC, 2007) and
to analyze population copy number variation (CNV) (McCarroll and others, 2006). These methods have
also been successfully applied to examine CNV in cancers (Bignell and others, 2004; Weir and others,
2007). Modern platforms such as the affymetrix genome-wide SNP6.0 platform contain additional non-
polymorphic probes, designed to give greater genomic resolution of copy number in regions of lower SNP
density. Alternative technologies such as molecular inversion probes (MIPs) (Wang, Li, and others, 2007)
and SNP bead arrays (Collela and others, 2007; Wang, Moorhead, and others, 2007; Peiffer and others,
2007) have similarly been used and produce allelic ratios that can be used to infer “allelic” copy number.
All these platforms require algorithms to infer these features.
Methods to extract copy number segmentation range from circular binary segmentation to hierarchical
clustering (Huang and others, 2007; Laframboise and others, 2005, 2006; Li and others, 2008; Li and
Zhu, 2007; Marioni and others, 2007; Olshen and others, 2004; Rueda and Diaz-Uriarte, 2007; Xing and
others, 2007). Hidden Markov models (HMMs) have proven to be a particularly powerful tool in this ﬁeld
(Beroukhim and others, 2006; Colella and others, 2007; Fridlyand and others, 2004; Lamy and others,
2007; Scharpf and others, 2008; Shah and others, 2006; Stjernqvist and others, 2007) and have been used
to identify LOH in addition to copy number segmentation. A comparison of various methods can be found
in Baross and others (2007).
There are also a variety of methods by which SNP genotypes are classiﬁed (Affymetrix (I), 2006;
Affymetrix (II), 2006; Carvalho and others, 2007; Giannoulatou and others, 2008; Lamy and others,
2006; Hua and others, 2007; Rabbee and Speed, 2006; Xiao and others, 2007).
Increasingly, methods are offering more integrated approaches to the 3-fold problem of estimating
total copy number across the genome, ﬁnding the allelic ratio of segments, and identifying the true
genotype of SNPs. These include the VanillaICE package from Scharpf and others (2008) that takes
SNP data consisting of copy number intensities and genotypes (classiﬁed as heterozygous or homozy-
gous) and implement an HMM. The states are designed to capture trends in copy number and do not
resolve copy number into its allelic integer components. However, it is a generic method for SNP data
requiring no training data that is quick to implement only requiring data from a single sample. The
mixed model approach of Wang, Carvalho, and others, (2007) harnesses patterns of genotype cluster-
ing across multiple samples with a mixed model approach to infer both allelic copy number and geno-
type at individual SNPs. The calculations are done on a per SNP basis and treat consecutive SNPs
independently. Accurate segmentation and break-point estimation will require smoothing (such as with
an HMM), which can be critical in cancer studies when it is desirable to know if a particular break
point is disrupting a gene’s function, for example. The PennCNV (Wang, Li, and others, 2007) and
Birdsuite packages (Korn and others, 2008) are the most comprehensive, providing allelic copy number
and genotype inference for illumina SNP bead arrays and the affymetrix genome-wide SNP6.0 arrays,
respectively.
This work considers the problems that arise when cancer data is analyzed using these methods and
discusses bespoke techniques that may be applied to circumvent these issues. Speciﬁcally, cancer is fre-
quency aneuploid in nature, which causes a systematic bias in preprocessing techniques utilized by these
methods. This can also result in the misalignment of copy number states with these algorithms. This prob-
lem is explored in more detail in Section 2. We then introduce preprocessing and segmentation techniques
suitable for cancer data. This method is validated using the affymetrix genome-wide SNP6.0 platform166 C. D. GREENMAN AND OTHERS
upon 460 wild-type and 755 cancer samples using a range of independent validation methods. A discus-
sion completes the paper.
2. CANCER ASSOCIATED BIASES
Cancer samples are known to commonly exhibit aneuploidy (Rajagopalan and Lengaue, 2004) with many
quadraploid and triploid samples, for example. Such variable ploidy affects the preprocessing used in
such algorithms. More speciﬁcally, when seeding DNA to a microarray plate, the quantity is controlled
by ﬁxing the mass of DNA used. For noncancerous samples, cells in different samples have very sim-
ilar amounts of DNA (i.e. from a diploid genome). A constant mass of DNA then effectively ﬁxes the
number of cells in each well on the plate, and the signals derived from each SNP allele are directly pro-
portional to the allelic copy number for all samples. These signals are sensitive enough to distinguish
allelic differences as seen in Figure 1(A), where the allelic intensities for a single SNP across a set of
461 normals clearly cluster according to the 3 wild-type genotype classes AA, AB, and BB. Such a struc-
ture is required for both Birdsuite and the mixed model approach of Wang, Carvalho, and others (2007).
For example, Birdsuite correctly identiﬁed the heterozygous state across a sample of 108 cancer samples
genotyped in only 70.13% of cases when compared to cDNA genotypes, far lower than ﬁgures reported
using benchmarking with wild-type cells.
BecausetheDNAdeliveredtoeachwellinamicroarrayplateiscontrolledbytotalmass, aquadraploid
sample will have half the number of cells seeded than a diploid sample. If 2 such samples have a region of
identical copy number, then wells designed to hybridize within this region will produce half the signal in
Fig. 1. Allelic intensities for a single SNP across multiple samples. (A) The A allele intensity is plotted against the B
allele intensity for each wild-type training sample at a single polymorphic probe. The MAP estimates of the linearly
separated mean allelic intensities for genotypes AA, AB, and BB are indicated in red. (B) The same allelic intensities
are plotted using the cancer samples. The signiﬁcant reduction in clustering is evident.Predicting integral copy numbers in cancer 167
the quadraploid sample than from the diploid sample. In particular, the signal is no longer proportional to
copy number, which will produce biases in any inference making this assumption. This adversely affects
theclusteringofthealleliccopynumberintensitiesbygenotype.Figure1(B)displaystheallelicintensities
for the same SNP as Figure 1(A) across a series of cancers, where the clustering is clearly compromised.
Although this effect could in theory be corrected by incorporating the ploidy of the cancer, this is usually
not a priori knowledge and would require spectral karyotyping (SKY) or ﬂow sorting the samples to
control the total number of cells.
The deviations in ploidy are readily observed via SKY. For example, using cancer cell line samples
HCC1806 (diploid), HCC1187 (triploid), and ZR-75-30 (quadraploid), the average copy number of each
chromosome was calculated using SKY (Howarth and others, 2008), and using Birdsuite upon SNP6.0
array data. The results can be seen in Figure 2 (and Supplementary Figure 2, available at Biostatistics
online) where Birdsuite does not capture differences in ploidy revealed by SKY.
These data show that although current integrative methods such as those of Scharpf and others (2008),
Wang, Carvalho, and others (2007) and Korn and others (2008) work well for integrated copy number
analyses in wild-type cells, these methods are less applicable to cancer samples and exhibit greatest error
where the ploidy departs from normal. A bespoke preprocessing procedure that captures the departure
from the normal clustering seen in Figure 1(B), and a segmentation routine that can calibrate to unusual
ploidy, and ultimately provide accurate integrated allelic copy number and genotyping analyses in cancer,
is thus desirable.
Tothisend, wenextintroducethe2stageprocedurepredictintegralcopynumbersincancer(PICNIC).
We ﬁrst introduce a preprocessing step that utilizes the genotype structure observed by others (Wang,
Fig. 2. Genome-wide copy number estimates of diploid, triploid, and quadraploid samples HCC1806, HCC1187,
and ZR-75-30, respectively. Copy number estimates are obtained using SKY (dashed), Birdsuite (red), and PICNIC
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Carvalho, and others, 2007; Korn and others, 2008) in normal tissues to convert the raw cancer data into
copy number and genotype intensities. We then introduce a Bayesian HMM to identify segments of ﬁxed
integer allelic copy number using the data produced by the preprocessing step. We also use the model to
classify the SNPs into their complex cancer genotypes.
3. CANCER BESPOKE METHODS
The preprocessing is essentially composed of 2 steps; a microarray plate correction and a normalization
step. The segmentation step then follows.
Across the sample set, the total probe intensity from each array varies substantially due to different
running times and conditions in the experimental process. In order to reduce this “microarray plate”
variation, we simply dividing all intensities by the total microarray signal from each sample.
The normalization step is a correction for the probe variation observed in Figure 1(B). We ﬁrst need
to gain an understanding of the wild-type behavior at each probe. This is achieved by ﬁtting a mixture of
bivariate normal distribution to the 3 clusters observed in Figure 1(A). A Bayesian approach helps with
this ﬁtting where the clustering structure is less clear with less informative SNPs. This results in maximum
a priori (MAP) estimates (Ag, Bg) representing the mean cluster positions corresponding to genotypes
g ∈{ AA, AB, BB}. These are assumed to align linearly so that,
⎧
⎪ ⎪ ⎪ ⎨
⎪ ⎪ ⎪ ⎩
(AAA, BAA) = (A0 + 2A1, B0),
(AAB, BAB) = (A0 + A1, B0 + B1),
(ABB, BBB) = (A0, B0 + 2B1).
(3.1)
We next utilized this information to transform cancer data into a copy number intensity rct and a genotype
intensity ϑct. We would like any point (x A
ct,xB
ct) on the line passing through the 3 genotype clusters to
have a copy number intensity of unity. We ﬁrst linearly transform the intensities to map clusters AA, AB,
and BB to mean positions (1,3), (2,2), and (3,1), and map the residual intensity loci (A0, B0) to (1,1).
The genotype intensity ϑct is then deﬁned to be the (normalized) angle from the origin to the transformed
cancer intensities. We then deﬁne transformation,
(rct,ν ct) =
 
A1xB
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. (3.2)
This completes the preprocessing. Examples can be seen in Figures 3(A) and (B), where copy number and
genotype intensities for genomic regions of cancer cell line HCC1187 are displayed. The combination of
copy number and genotype intensities clearly reveal the full range of allelic copy numbers present in the
samples.
The ﬁnal step involves the segmentation and genotyping of the data, which was achieved using a
Bayesian HMM. Such methods have previously been successfully applied to allelic copy number such as
with PennCNV and Birdsuite. The states used tend to encompass a large range of genotypes observed in
genetic disease. However, cancer does not exhibit such a wide range, and the HMM requires a speciﬁc
copy number state space relevant to cancer. Speciﬁcally, prior to the formation of a somatic copy number
variant, there is 1 copy of each parental wild-type segment, and the genotypes of the SNPs within the
region are AA, AB, or BB. After the copy number variant is formed, the segment contains g and h − g
copies of each parental segment (h segments in total), ordered such that g  h − g. Here, g and h − g
denote the “minor” and “major” copy numbers, respectively. For a segment of the genome of ﬁxed total
copy number h, there are  h/2 +1 possible copy number states, indexed by g = 0,1,..., h/2 .F o rPredicting integral copy numbers in cancer 169
Fig. 3. Absolute copy number, genotype intensity, and break-point likelihoods for cancer cell lines HCC1187. Each
plot contains 3 sections. First are copy number intensities, followed by genotype intensities. Associated genotypes
are indicated. Green and blue lines indicate total and minor estimated copy number. Black and red lines represent
heterozygous and homozygous segments. Finally, the likelihoods of state change are plotted. The horizontal scale is
genomic position in megabases. Vertical scales represent chromosomal copy number. (A and B) derive from chromo-
somes 14 and 19, respectively.
Table 1. Genotype classes by copy number states. A description of possible genotypes for the ﬁrst few
minor and major copy numbers
Total copy Number of Number of minor alleles (g)
number (h) genotype 0 (LOH) 1 2
classes
0 1 DEL – –
11 {A,B} ––
22 {AA,BB}{ AA,AB,BB} –
32 {AAA,BBB}{ AAA,AAB,ABB,BBB} –
43 {AAAA,BBBB}{ AAAA,AAAB,ABBB,BBBB}{ AAAA,AABB,BBBB}
53 {AAAAA,BBBBB}{ AAAAA,AAAAB, {AAAAA,AAABB,
ABBBB,BBBBB} AABBB,BBBBB}
each state pair (g,h), we get 4 genotypes; {A × h},{A × (h − g),B × g},{A × g,B × (h − g)},o r
{B × h}. These genotypes can coincide where LOH is present (g = 0) or we have an even number
of chromosomes (g = h/2). This results in between 1 and 4 possible genotypes within a segment of
copy number state (g,h). This information is summarized in Table 1, examples of which can be seen in
Figure 3.
The Bayesian HMM was ﬁtted with the Baum–Welch algorithm and segmented with the Viterbi
algorithm (Rabiner, 1989). This process is sensitive to the initial seeding of the parameters, which re-
quires a heuristic approach to accurately calibrate copy number with copy number intensity. The forward–
backward equations can then be used to infer several features of interest including genotype classiﬁcation170 C. D. GREENMAN AND OTHERS
and to associate conﬁdence to break-point estimates. Full details of these methods can be found in Sup-
plementary Text 1, available at Biostatistics online.
4. VALIDATION
In order to assess performance, we examined the HMM’s prediction of deletions, LOH, ampliﬁcations,
breakpoints, copynumberestimation, andgenotypingusingcancercelllinesculturedfromavarietyoftis-
sue types. We also benchmarked these results against Birdsuite. These are considered below and summa-
rized in Table 2. Further details can be found in Supplementary Table 1, available at Biostatistics online.
The predicted copy number of PICNIC and Birdsuite was assessed by comparing results to copy
numbers obtained using SKY (Howarth and others, 2008). This was determined for HCC1806 (diploid),
HCC1187 (triploid), and ZR-75-30 (quadraploid). The genomic extent (Mb) of correctly and incorrectly
predicted copy numbers were then determined, giving 65.35%, 80.56%, and 77.67% for PICNIC, respec-
tively. The values for Birdsuite are 59.83%, 52.55%, and 6.43%, respectively. Although results for the
diploid sample are similar, the improvement for the more complex genomes using the cancer speciﬁc
software is clear, as can be seen in Figure 2. We also used the break points estimated by Howarth and
others (2008) in these 3 samples to determine how many were detected using PICNIC and Birdsuite.
PICNIC identiﬁed 55.41%, 46.81%, and 75.51%, and Birdsuite was comparible identifying 56.76%,
48.94%, and 63.27%, respectively.
To investigate speciﬁcity and sensitivity of deletion detection, 7 known tumor suppressor genes
(CDKN2C, CDKN2A, PTEN, RB1, MAP2K4, SMAD4, and STK11) were screened for the presence
of deletions using PICNIC and Birdsuite. The same genes were also screened using multiplex polymerase
chain reaction (PCR) with a probe per exon. These 2 independent methods were then compared across
102 cell lines. A total of 38/49 (77.55%) deletions were detected by PICNIC, showing excellent sensitivity
and speciﬁcity. This reduces to 59.18% for Birdsuite.
In order to test the performance of LOH prediction, the repeat lengths of both alleles of approximately
400 microsatellite markers are derived. As both alleles derive from a wide choice of counts, an identical
pair of repeat lengths is indicative of LOH and was designated as so. The HMM LOH status at each marker
was compared to the microsatellite LOH status. Excellent speciﬁcity was shown, with only 4989/93410
(5.34%) markers with 2 distinct microsatellite repeat lengths being identiﬁed as LOH by PICNIC.
Although sensitivity was lower, with 40970/70391 (58.2%) agreement, this is consistent with the rate
that markers produced identical repeat length alleles (32.7% from normal samples). Segmental LOH
status could not be obtained from Birdsuite.
To test the performance of ampliﬁcation prediction, quantitative PCR (qPCR) with 20 probes was
implemented comparing the copy number of a commonly ampliﬁed gene cluster containing GLO1 to the
reference control gene β-actin. The relative copy number of this cluster to the reference gene was also
calculated from the predicted copy number states for both methods and results compared. The average
relative copy number across this region differed from qPCR by 5.44% and 11.51% using PICNIC and
Birdsuite, respectively.
PICNIC provides genotype likelihoods for all polymorphic probes. Maximum likelihood was then
used to determine whether the probe was heterozygous or specify the homozygous allele. To validate the
classiﬁcations, cDNA of 20 probes were genotyped across 108 cell lines. A total of 1406/1448 (97.10%)
homozygous SNPs were correctly identiﬁed as homozygous and 441/467 (94.43%) as heterozygous.
These ﬁgures drop to 78.12% and 45.27%, respectively, for Birdsuite.
In summary, although using generalized copy number software upon cancer data can lead to system-
atic errors which are most apparent with anueploid genomes, techniques bespoke to tumor data, such as
PICNIC, provide an effective means by which these biases can be overcome and provide accurate infor-
mation regarding allelic integer copy number and genotype information in cancer.P
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Table 2. Validation methods. Results are summarized for validation of homozygous deletions, genotypes, LOH, copy number, break points, and
ampliﬁcations. Statistics used include true positive and false positive rates (TPR, FPR), the percentage of correct calls and the mean error
Data type Validation set Test set Statistic PICNIC Birdsuite
Copy number SKY HCC1806(diploid) % Correct 65.35% 59.83%
Copy number SKY HCC1187(triploid) % Correct 80.56% 52.55%
Copy number SKY ZR-75-30(quadraploid) % Correct 77.67% 6.43%
Homozygous deletions conﬁrmatory PCR for 7 known TSGs 102 cell lines TPR (FPR) 77.55% (0.15%) 59.18% (0.15%)
Genotypes cDNA hom genotyping 108 cell lines % Correct 96.45% 70.13%
LOH 400 microsatellite markers 755 cell lines TPR (FPR) 58.20% (5.34%) NA
Break points SKY HCC1806(diploid) TPR 55.41% 56.76%
Break points SKY HCC1187(triploid) TPR 46.81% 48.94%
Break points SKY ZR-75-30(quadraploid) TPR 75.51% 63.27%
Amplicons qPCR of GLO1 ampliﬁed cluster 58 cell lines Mean error 5.44% 11.51%172 C. D. GREENMAN AND OTHERS
5. DISCUSSION
Methods to investigate the genotypes and CNV in tumor samples are an important component of cancer
genomics. Although oligonucleotide platforms such as affymetrix genome-wide SNP6.0 arrays have been
successfully applied to wild-type genetics with integrative algorithms such as VanillaICE, that of Wang,
Carvalho, and others (2007), and Birdsuite, the aneuploid nature of cancer produces biases that require
more bespoke methods. We have introduced an algorithm that successfully caters for these effects. These
techniques allow a complete portrait of integral allelic copy number in cancer to be derived for the full
range of aneuploidy observed in cancer.
This process (PICNIC) was implemented with a training set of 461 normal samples and 755 cancer
cell lines from a wide spectrum of tissue types and histologies using data obtained through affymetrix
genome-wide SNP6.0 array technology and implemented with Matlab. The method was shown to ac-
curately predict integer major and minor copy numbers, complex cancer genotypes, homozygous dele-
tion, ampliﬁcation, and regions of LOH with good break-point accuracy. This allows detection of subtle
changes such as copy neutral LOH and hemizygous deletion providing a more complete proﬁle of CNV
in cancer genomes.
The preprocessing training steps were implemented using 461 normal samples and took approxi-
mately 3 Ghz × 100h computing time to complete for the affymetrix genome-wide SNP 6.0 array.
This step only needs to be done once and the renormalization can then be implemented quickly on
many samples. The segmentation step was implemented for the 1216 wild-type and cancer samples
in approximately 3 Ghz × 3h running time per sample (a multinode farm was used in application),
with a maximum segmented copy number of 15. This time could be reduced by dropping either
the maximum segmented copy number or dropping the Baum–Welch optimization and just using Viterbi
segmentation with seeded parameters. The running time scales linearly with the number of
samples and the number of probes but scales quadratically with the maximum segmented copy
number.
Data quality was occasionally compromised due to various factors. Experimental protocols or con-
ditions could produce noisy data, readily ﬁxed by optimization, or repeat runs. Contaminated samples
produce spurious results, Supplementary Figure 1, available at Biostatistics online exhibiting a putative
example, but such cases can be resourced. Although cell lines are typically composed of a single outgrown
clone, there is some evidence that cell lines occasionally contain multiple subclones with different copy
numbers in different genomic regions. Regions that contain distinct copy number by clone will likely
produce unexpected (nonintegral) copy number intensities. Such mosaicism provides a difﬁcult problem
for the entire ﬁeld of CNV in cancer. Chromosome 11 of sample HCC1187 is a probable example of this
(see Figure 1(B) in Supplementary Text 1, available at Biostatistics online), where the mean copy number
intensityforthischromosomeisbetweenthemeanvaluesassociatedwithcopynumbersof3and4).Geno-
type intensities were also affected, reproducing the mean signal from all present clones. Finally, we note
thatthisalgorithmhasonlybeenappliedtocelllines, andthatprimarysampleswithnormaltissuecontam-
ination or containing multiple dominant clones may not segment as well. We note that the preprocessing
step is suitable for all samples, however, irrespective of any mosaicism or normal contamination that may
be present.
These experiments have produced a signiﬁcant volume of invaluable data, aiding the identiﬁcation
of candidate tumor suppressor genes, oncogenes, and gene fusions. The segmented data of all analyzed
samples can be viewed at http://www.sanger.ac.uk/cgi-bin/genetics/CGP/cghviewer/CghHome.cgi. The
raw data (*.cel ﬁles) are an open resource available at www.sanger.ac.uk/genetics/CGP/Archive/. The
algorithm was coded in (UNIX) Matlab and both the preprocessing and segmentation algorithms are avail-
able under a free Berkeley software distribution license from www.sanger.ac.uk/genetics/CGP/
Software/.Predicting integral copy numbers in cancer 173
SUPPLEMENTARY MATERIAL
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